A detailed history of High Point Advisor Group LLC transactions in Haleon PLC stock. As of the latest transaction made, High Point Advisor Group LLC holds 35,555 shares of HLN stock, worth $344,883. This represents 0.02% of its overall portfolio holdings.

Number of Shares
35,555
Previous 32,618 9.0%
Holding current value
$344,883
Previous $269,000 39.78%
% of portfolio
0.02%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$8.32 - $10.7 $24,435 - $31,425
2,937 Added 9.0%
35,555 $376,000
Q2 2024

Aug 08, 2024

BUY
$8.01 - $8.64 $36,805 - $39,700
4,595 Added 16.4%
32,618 $269,000
Q1 2024

May 14, 2024

SELL
$8.02 - $8.67 $291,166 - $314,764
-36,305 Reduced 56.44%
28,023 $237,000
Q4 2023

Mar 26, 2024

BUY
$7.78 - $8.62 $500,471 - $554,507
64,328 New
64,328 $529,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $44.8B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track High Point Advisor Group LLC Portfolio

Follow High Point Advisor Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Point Advisor Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Point Advisor Group LLC with notifications on news.